Medicus Pharma (NASDAQ:MDCX) said on Monday that new analysis of data from a mid-stage clinical trial of its SkinJect ...
E! Online on MSN
Amanda Peet Shares Breast Cancer Diagnosis
Amanda Peet detailed her recent breast cancer diagnosis in a new essay, sharing that her health battle coincided with both of ...
CEO Dr. Raza Bokhari talked with Proactive about the company’s newly reported topline Phase 2 results for its microneedle ...
Adjust your morning skincare routine accordingly.
They did not think skin cancer would strike them. One thought it was something that happened to older people with a genetic history, and the other thought it affected people with fair skin.Skin cancer ...
Simone Boseman reflected on her late husband Chadwick Boseman’s colon cancer battle, over five years after his death in 2020: ...
Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid ...
Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid immediate surgical intervention. PHILADE ...
Skin cancer is the most common cancer in the U.S. Learn the main types, warning signs, and the prevention tip dermatologists say not to skip.
Opinion
American Academy of Dermatology Association statement on FDA withdrawing proposed sunlamp regulation
The American Academy of Dermatology Association is disappointed that the Food and Drug Administration (FDA) is withdrawing its proposed rule on sunlamp regulation, which would have restricted ...
Detailed price information for Medicus Pharma Ltd (MDCX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results